Koninklijke DSM N.V. carries a market capitalization of 4.40B, placing it among publicly traded companies globally. Its enterprise value stands at 26.49B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.40B |
| Enterprise Value | 26.49B |
Koninklijke DSM N.V. currently has 172.22M shares outstanding.
| Shares Outstanding | 172.22M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Koninklijke DSM N.V. trades at a trailing price-to-earnings ratio of 44.44. The price-to-sales ratio is 2.77, and the price-to-book ratio stands at 2.92.
| PE Ratio | 44.44 |
| PS Ratio | 2.77 |
| PB Ratio | 2.92 |
| P/TBV Ratio | 7.79 |
| P/FCF Ratio | 15.70 |
| P/OCF Ratio | 15.88 |
On an enterprise value basis, Koninklijke DSM N.V. trades at an EV/EBITDA multiple of 30.21 and an EV/FCF ratio of 17.53. The EV/Sales ratio of 3.09 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 30.21 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.09 |
| EV / EBITDA | 30.21 |
| EV / EBIT | 30.21 |
| EV / FCF | 17.53 |
Koninklijke DSM N.V. maintains a current ratio of 2.42, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.42 |
| Quick Ratio | 0.41 |
| Debt / Equity | 47.90 |
| Debt / EBITDA | 4.09 |
| Interest Coverage | N/A |
Koninklijke DSM N.V. posts a return on equity of 6.60 and a return on invested capital of 6.60.
| Return on Equity (ROE) | 6.60 |
| Return on Assets (ROA) | 3.84 |
| Return on Invested Capital (ROIC) | 6.60 |
| Return on Capital Employed (ROCE) | 4.69 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Koninklijke DSM N.V. has paid 117.00M in income taxes, reflecting an effective tax rate of 18.40.
| Income Tax | 117.00M |
| Effective Tax Rate | 18.40 |
Koninklijke DSM N.V.'s stock has declined approximately -36.90773% over the past 52 weeks. The 50-day moving average sits at 26.01, while the 200-day moving average is 58.04.
| Beta (5Y) | N/A |
| 52-Week Price Change | -36.90773% |
| 50-Day Moving Average | 26.01 |
| 200-Day Moving Average | 58.04 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Koninklijke DSM N.V. generated 8.57B in revenue and converted that into 534.00M in net income, yielding earnings per share of 2.84. EBITDA reached 877.00M, while operating income came in at 877.00M.
| Revenue | 8.57B |
| Gross Profit | N/A |
| Operating Income | 877.00M |
| Pretax Income | 636.00M |
| Net Income | 534.00M |
| EBITDA | 877.00M |
| EBIT | 877.00M |
| Earnings Per Share (EPS) | 2.84 |
Koninklijke DSM N.V. holds 914.00M in cash and equivalents against 3.59B in total debt, resulting in a net debt position of 2.50B. Total book value stands at 8.13B, with working capital of 3.18B providing operational flexibility.
| Cash & Cash Equivalents | 914.00M |
| Total Debt | 3.59B |
| Net Debt | 2.50B |
| Equity (Book Value) | 8.13B |
| Book Value Per Share | 47.45 |
| Working Capital | 3.18B |
Koninklijke DSM N.V. produced 1.49B in operating cash flow over the past twelve months. After subtracting -17.00M in capital expenditures, free cash flow totaled 1.48B - equivalent to 8.62 per share.
| Operating Cash Flow | 1.49B |
| Capital Expenditures | -17.00M |
| Free Cash Flow | 1.48B |
| FCF Per Share | 8.62 |
Koninklijke DSM N.V. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of 10.23 and net profit margin of 6.23 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | 10.23 |
| Pretax Margin | 7.42 |
| Profit Margin | 6.23 |
| EBITDA Margin | 10.23 |
The company's payout ratio of 25.66 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.74 |
| Dividend Yield | N/A |
| Payout Ratio | 25.66 |
| Shareholder Yield | -0.35 |
| FCF Yield | 6.37 |
Koninklijke DSM N.V.'s most recent stock split took place on October 14, 2005 with a 1:2 split ratio.
| Last Split Date | 10/14/2005 |
| Split Ratio | 1:2 |
Koninklijke DSM N.V. posts an Altman Z-Score of 4.72, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.72 |